New Data Shows ECHELON FLEX™ Powered Staplers Associated with Clinical And Economic Benefits Compared to Medtronic ENDO GIA™ Manual Staplers
One of the largest retrospective studies of surgical stapling reports fewer bleeding complications, shorter OR time, and reduced hospital costs in bariatric procedures
CINCINNATI, Ohio – March 9, 2017 – Ethicon*, a leading global provider of medical devices, today announced that one of the largest retrospective studies of surgical stapling ever conducted was published in The Journal of Medical Economics. The study showed that use of ECHELON FLEX™ Powered Staplers was associated with significant clinical and economic benefits including 47% lower rate of bleeding complications1, 14% shorter operating room time2, and 13% lower overall hospital costs3 when compared to the Medtronic ENDO GIA™ with Tri-Staple™ Technology and other manual staplers.
The real world study is a retrospective analysis of hospital discharge data from the Premier Perspective® Hospital Database consisting of approximately 700 hospitals and over 21,000 patients who underwent laparoscopic bariatric surgery between 2012 and 2015. This study revealed that ECHELON FLEX™ Powered Staplers, the predominantly used Ethicon stapling system, were associated with fewer bleeding complications compared to the most widely used Medtronic stapling system, the ENDO GIA™. The lower hospital costs found in this study, an average of $1,777 per patient with the use of Ethicon Powered Staplers, is associated with over a $35 million reduction to the healthcare burden for the procedures conducted in this study.
Surgical stapling devices are widely used for transection and anastomosis in both open and laparoscopic surgical oncology and bariatric procedures. Surgeons often choose between manual and powered stapling devices based on their training, professional experience, and perceived cost benefits. This study, the first to compare economic and clinical outcomes linked to the type of stapler used, can help inform this decision.
“Ethicon is committed to bringing to market innovative products designed to reduce complications in the most challenging oncology and metabolic surgical cases,” says Tom O’Brien, Vice President, Global Endomechanical Platform Leader at Ethicon. “Through a deep understanding of how our device stabilizes and controls tissue movement, Powered ECHELON FLEX™ enables surgeons to achieve greater precision at the staple line, which could contribute to better patient outcomes as suggested by the Premier data.”
The study, Comparison of Economic and Clinical Outcomes between Patients Undergoing Laparoscopic Bariatric Surgery with Powered vs. Manual Endoscopic Surgical Staplers, is available online and will appear in the March 2017 issue of The Journal of Medical Economics. The data for this study was derived from the Premier Perspective® Hospital Database, one of the largest, statistically certified hospital databases in the world containing real world data on hospital resource use, costs, outcomes and patient/hospital demographics.
From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon, part of the Johnson & Johnson Medical Devices Companies, has made significant contributions to surgery for more than 60 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world’s most pressing health care issues, and improve and save more lives. Through Ethicon’s surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treating serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at www.ethicon.com, and follow us on Twitter @Ethicon.
- * Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, Inc. and certain of their affiliates. Ethicon Endo-Surgery, Inc. is the legal manufacturer of ECHELON FLEX™ Powered Staplers. All other trademarks are the property of their respective owners.